Malignant PEComa (Perivascular Epithelioid Cell Tumors)
1 clinical trials · Condition
◉ Watch Malignant PEComa (Perivascular Epithelioid Cell Tumors)
| Record | Firm | Date |
|---|---|---|
| A Phase II Study of Orally Administered BEZ235 Monotherapy in Patients With Metastatic or Unresectable Malignant PEComa (NCT01690871) | Novartis Pharmaceuticals | 2012-09-01 |
Track Malignant PEComa (Perivascular Epithelioid Cell Tumors) automatically
Every clearance here is in the API, with alerts when new ones post.